Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Starzyk

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|September 11, 2023
TESOGENASE, An Engineered Nuclease Editor for Enhanced Targeted Genome IntegrationHangu Nam, Keqiang Xie, Ishita Majumdar, et al.
Research Square|November 14, 2023
Engineering Tripartite Gene Editing Machinery for Highly Efficient Non-Viral Targeted Genome IntegrationHangu Nam, Keqiang Xie, Ishita Majumdar, et al.
Molecular Therapy. Oncology|May 6, 2026
Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activityJiao Wang, Yao Sun, Jakob Starzyk, et al.
Nature Communications|May 16, 2025
Engineering tripartite gene editing machinery for highly efficient non-viral targeted genome integrationHangu Nam, Keqiang Xie, Ishita Majumdar, et al.
Nature Biotechnology|December 11, 2024
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integrationKeqiang Xie, Jakob Starzyk, Ishita Majumdar, et al.
Nature|March 12, 2026
Immune evasive DNA donors and recombinases license kilobase-scale writingConnor J Tou, Keqiang Xie, Joana Ferreira da Silva, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|September 11, 2023
TESOGENASE, An Engineered Nuclease Editor for Enhanced Targeted Genome IntegrationHangu Nam, Keqiang Xie, Ishita Majumdar, et al.
Research Square|November 14, 2023
Engineering Tripartite Gene Editing Machinery for Highly Efficient Non-Viral Targeted Genome IntegrationHangu Nam, Keqiang Xie, Ishita Majumdar, et al.
Molecular Therapy. Oncology|May 6, 2026
Non-viral targeted integration at the CISH locus enables CAR-NK cell engineering with enhanced anti-tumor activityJiao Wang, Yao Sun, Jakob Starzyk, et al.
Nature Communications|May 16, 2025
Engineering tripartite gene editing machinery for highly efficient non-viral targeted genome integrationHangu Nam, Keqiang Xie, Ishita Majumdar, et al.
Nature Biotechnology|December 11, 2024
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integrationKeqiang Xie, Jakob Starzyk, Ishita Majumdar, et al.
Nature|March 12, 2026
Immune evasive DNA donors and recombinases license kilobase-scale writingConnor J Tou, Keqiang Xie, Joana Ferreira da Silva, et al.
Pageof 1